Inkmaker Shanghai doubles size of factory to meet demand during Covid-19
Inkmaker Group announces that as of 7 April 2020 Inkmaker Shanghai will begin operating from a new 35,000 square feet facility, double the size of its current factory space, to meet with the demands due to the recent escalation in workload and orders.
The expansion, part of IM Group’s investment plan, started with the acquisitions of the businesses of Rexson Systems and Vale-Tech in the UK last October, and more recently those of Tecnopails in Italy. "We had originally planned for this expansion later in the year but, in view of the increased workload as a consequence of the Covid-19 situation, we have brought our plans forward to meet the demand head on,” said Kar Seng, General Manager of Inkmaker Shanghai and board member of the Inkmaker Group.
The move comes at a much needed moment for the group, which recently adapted to government recommendations in the most-at-risk countries where it is present, with most employees working in remote from home. "These are challenging times, but we are well placed to take full advantage of our investments: factories—not just representative agents—in different countries are ensuring we can quickly shift workorders and physically continue production to ensure deliveries are met,” said Roberto Guerra, CEO Asia, Inkmaker Group.
Looking for chemical products? Let suppliers reach out to you!
2026-07-22
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
POND GROUP Acquires All Grace, Boosting Cosmetics Market Share by 20%
-
Freudenberg Group acquires fastener coating enterprises
-
Pfizer's paxlovid reduces the risk of COVID-19 by 26%
-
The battle between Pfizer and Gilead over COVID-19 drugs will continue
-
1200 cases were newly prescribed by Junshi Biologic for mild to moderate disease
-
Twenty-five COVID-19 Vaccines In China Enter Stages Of Clinical Trials
-
Pfizer to Increase Production Capacity of COVID-19 Oral Drugs, Invest 120 Million US Dollars
-
Anke Bio and Afana Collaborate on mRNA Vaccines for Mutant Strains Such as COVID-19 Omicron
-
As Low as $25/session! Pfizer's COVID-19 Oral Drug Paxlovid Generic Drug Price Released
-
Survey On Corona Deaths By Country
Recommend Reading
-
Titan Technology Makes Bold Move with 55.85 Million Yuan Acquisition of UK Biochemical Firm ASL — What's Behind the Deal?
-
February Maleic Anhydride Prices Generally Increased in China
-
Polyester bottle chip prices first fell then rebounded in February, weakening again at the end of the month in China
-
Unilever Invests 30 Billion Forints in New Deodorant Plant in Hungary
-
Sherwin-Williams Completes Acquisition of BASF's Decorative Paints Business in Brazil for $1.15 Billion
-
Does Ammonia Bleach Clothes? Is It Safe to Use on Laundry?
-
ECHEMI High Quality Inquiries (21-25 Jul)
-
February Acetic Acid Market Fluctuates
-
February phosphate market trend shows strong increase in China
-
February Adipic Acid Market Fluctuates and Rises in China